[1] CAMILLERI M,NULLENS S,NELSEN T.Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea[J].Digestive Diseases and Sciences,2012,57(1):19-27.
[2] 徐立新.嗜酸乳杆菌和亚油酸治疗抗生素引起大鼠腹泻的研究[D].硕士学位论文.泸州:泸州医学院,2011:4-5.
[3] 曾娟.肠易激综合征肠黏膜屏障功能的研究[D].博士学位论文.济南:山东大学,2008:10-12.
[4] GAREAU M G,SHERMAN P M,WALKER W A.Probiotics and the gut microbiota in intestinal health and disease[J].Nature Reviews Gastroenterology & Hepatology,2010,7(9):503-514.
[5] SUN Y J,CAO H J,SONG D D,et al.Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats[J].Digestive Diseases and Sciences,2013,58(6):1528-1536.
[6] GUARINO A,GUANDALINI S,LO VECCHIO A.Probiotics for prevention and treatment of diarrhea[J].Journal of Clinical Gastroenterology,2015,49(Suppl.1):S37-S45.
[7] OHLAND C L,MACNAUGHTON W K.Probiotic bacteria and intestinal epithelial barrier function[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2010,298(6):G807-G819.
[8] LING Z X,LIU X,CHENG Y W,et al.
Clostridium butyricum combined with
Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea[J].BioMed Research International,2015,2015:582048.
[9] 胡长霞.益生菌对轮状病毒性腹泻小鼠肠道屏障的影响及机制的探讨[D].硕士学位论文.武汉:华中科技大学,2013:5-6.
[10] TAKAHASHI M,TAGUCHI H,YAMAGUCHI H,et al.The effect of probiotic treatment with
Clostridium butyricum on enterohemorrhagic
Escherichia coli O157:H7 infection in mice[J].FEMS Immunology & Medical Microbiology,2004,41(3):219-226.
[11] BISSON J F,HIDALGO S,ROZAN P,et al.Preventive effects of different probiotic formulations on travelers' diarrhea model in Wistar rats:preventive effects of probiotics on TD[J].Digestive Diseases and Sciences,2010,55(4):911-919.
[12] PALOMAR M M,GALDEANO C M,PERDIGÓN G.Influence of a probiotic lactobacillus strain on the intestinal ecosystem in a stress model mouse[J].Brain,Behavior,and Immunity,2014,35:77-85.
[13] 李丹,吕妍,唐方.腹泻型肠易激综合征大鼠模型的建立[J].天津中医药,2009,26(3):240-242.
[14] 周干南,胡芝华,汪亚先,等.小鼠腹泻模型的制备与腹泻指数的应用[J].中草药,1994,25(4):195-196,199.
[15] 王新,韩月东,吴汉平,等.番泻叶提取物对小鼠胃肠运动及其组织形态学的影响[J].中国中西医结合杂志,2001,21(增刊):66-68.
[16] 兰梅,王新,吴汉平,等.番泻叶提取物对人肠上皮细胞生物学特性的影响[J].世界华人消化杂志,2001,9(5):555-559.
[17] SONG Z F,WU T X,CAI L S,et al.Effects of dietary supplementation with
Clostridium butyricum on the growth performance and humoral immune response in
Miichthys miiuy[J].Journal of Zhejiang University Science B,2006,7(7):596-602.
[18] 刘宗正,徐轲,王剑,等.酪酸菌对腹泻小鼠的治疗效果及其安全性[J].山东大学学报:医学版,2009,47(9):32-35.
[19] VENTOLA H,LEHTORANTA L,MADETOJA M,et al.Effects of the viability of
Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats[J].World Journal of Gastroenterology,2012,18(41):5925-5931.
[20] JOHNSTON S D,SMYE M,WATSON R P.Intestinal permeability tests in coeliac disease[J].Clinical Laboratory,2000,47(3/4):143-150.
[21] 李亚杰,赵献军.益生菌对肠道黏膜免疫的影响[J].动物医学进展,2006,27(7):38-41.
[22] LUYER M D,BUURMAN W A,HADFOUNE M,et al.Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock[J].Infection and Immunity,2005,73(6):3686-3692.
[23] 刘虎传,张敏红,李素霞,等.益生菌制剂对早期断奶仔猪肠道pH、黏膜形态结构和挥发性脂肪酸含量的影响[J].动物营养学报,2012,24(7):1329-1335.
[24] BRANISTE V,JOUAULT A,GAULTIER E,et al.Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats[J].Proceedings of the National Academy of Sciences of the United States of America,2010,107(1):448-453.
[25] EBNET K,AURRAND-LIONS M,KUHN A,et al.The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3:a possible role for JAMs in endothelial cell polarity[J].Journal of Cell Science,2003,116(19):3879-3891.
[26] TURNER J R.Molecular basis of epithelial barrier regulation:from basic mechanisms to clinical application[J].The American Journal of Pathology,2006,169(6):1901-1909.
[27] ENDO H,NIIOKA M,KOBAYASHI N,et al.Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats:new insight into the probiotics for the gut-liver axis[J].PLoS One,2013,8(5):e63388.
[28] MANTIS N J,ROL N,CORTHÉSY B.Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut[J].Mucosal Immunology,2011,4(6):603-611.
[29] SHOUVAL D S,OUAHED J,BISWAS A,et al.Interleukin 10 receptor signaling:master regulator of intestinal mucosal homeostasis in mice and humans[J].Advances in Immunology,2014,122:177-210.
[30] SHOUVAL D S,BISWAS A,GOETTEL J A,et al.Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function[J].Immunity,2014,40(5):706-719.
[31] MORAN C J,WALTERS T D,GUO C H,et al.IL-10R polymorphisms are associated with very-early-onset ulcerative colitis[J].Inflammatory Bowel Diseases,2012,doi:10.1002/ibd.22974.
[32] 任大勇.益生乳酸杆菌的黏附及免疫调节作用研究[D].博士学位论文.长春:吉林大学,2013:4-6.
[33] COCCIA M,HARRISON O J,SCHIERING C,et al.IL-1β mediates chronic intestinal in-flammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4
+ Th17 cells[J].The Journal of Experimental Medicine,2012,209(9):1595-1609.
[34] NEURATH M F.Cytokines in inflammatory bowel disease[J].Nature Reviews Immunology,2014,14(5):329-342.
